• Profile
Close

The preoperative C‐reactive protein–lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma

Head & Neck May 28, 2021

Ko CA, Fang KH, Hsu CM, et al. - In this study, the utility of preoperative C‐reactive protein (CRP)–lymphocyte ratio (CLR) as a prognostic biomarker in oral cavity squamous cell carcinoma (OSCC) was inquired. A retrospective analysis of 316 patients with OSCC managed with curative surgery, was conducted. Relative to other inflammatory combinations, CLR cutoff of 3.88 displayed optimal prognostic performance. There was not only a significant link of a higher preoperative CLR (≥3.88) with clinicopathological aggressiveness, but also unfavorable overall survival and disease‐free survival were predicted by it. In the light of these findings, peoperative CLR was concluded as a feasible prognostic biomarker in OSCC, and experts suggest the likely utility of the CLR‐based nomogram as a prognostic instrument in the era of personalized medicine.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay